(Q38123661)

29 August 2017

Heparin/heparan sulphate interactions with complement--a possible target for reduction of renal function loss? (English)

1 reference

29 August 2017

Azadeh Zaferani

1

1 reference

29 August 2017

Ditmer Talsma

2

1 reference

29 August 2017

Mareike K S Richter

3

1 reference

29 August 2017

Mohamed R Daha

4

1 reference

29 August 2017

Gerjan J Navis

5

1 reference

29 August 2017

Marc A Seelen

6

1 reference

29 August 2017

Jacob van den Born

7

1 reference

29 August 2017

language of work or name

English

0 references

publication date

22 July 2013

1 reference

Nephrology Dialysis Transplantation

29 August 2017

1 reference

29 August 2017

29

1 reference

29 August 2017

3

1 reference

29 August 2017

515-522

1 reference

New roles for innate immune response in acute and chronic kidney injuries.

29 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

How does proteinuria cause progressive renal damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

The innate immune response in ischemic acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Complement and renal transplantation: from donor to recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

C3 glomerulopathy: a new classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Alternative complement pathway assessment in patients with atypical HUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Basic and translational concepts of immune-mediated glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Complement regulators and inhibitory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Allograft rejection: effect of local synthesis of complement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

The role of complement in antibody-mediated rejection in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Intrarenal synthesis of complement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

21 January 2018

Proteoglycan sequence

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Heparan sulphate proteoglycans fine-tune mammalian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Heparan sulfate proteoglycans: structure, protein interactions and cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Cellular uptake of C4b-binding protein is mediated by heparan sulfate proteoglycans and CD91/LDL receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Pathophysiology of heparan sulphate: many diseases, few drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Differential substrate and inhibitor profiles for human MASP-1 and MASP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Effect of Heparin on Renal Function in Patients with Oliguria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Specific complement inhibition with heparin-coated extracorporeal circuits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Heparan sulfate-protein interactions: therapeutic potential through structure-function insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

Towards the assembly of heparin and heparan sulfate oligosaccharide libraries: efficient synthesis of uronic acid and disaccharide building blocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT243

21 January 2018

Identifiers

DOI

10.1093/NDT/GFT243

1 reference

29 August 2017

1 reference